What is the current stock price of Immunotech Laboratories, Inc. (IMMB)?

As of the latest market data, Immunotech Laboratories, Inc. (IMMB) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Immunotech Laboratories, Inc. (IMMB) pay a dividend?

Based on current data, Immunotech Laboratories, Inc. does not have a confirmed active dividend policy.

What is the market cap of Immunotech Laboratories, Inc.?

The current market capitalization of Immunotech Laboratories, Inc. (IMMB) is approximately unavailable.

IMMB

Immunotech Laboratories, Inc.·Healthcare

0.00

0.000%(+0.00)

Close Price

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Eco-Petroleum Solutions, Inc.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

IPO Date

2022-12-01

Beta

-77.02

Websitewww.immunotechlab.com↗